Abstract
Diabetes induces vasoregression, neurodegeneration and glial activation in the retina. Formation of advanced glycation endoproducts (AGEs) is increased in diabetes and contributes to the pathogenesis of diabetic retinopathy. CD74 is increased in activated microglia in a rat model developing both neurodegeneration and vasoregression. In this study, we aimed at investigating whether glucose and major AGE precursor methylglyoxal induce increased CD74 expression in the retina. Expression of CD74 in retinal microglia was analyzed in streptozotocin-diabetic rats by wholemount immunofluorescence. Nondiabetic mice were intravitreally injected with methylglyoxal. Expression of CD74 was studied by retinal wholemount immunofluorescence and quantitative real-time PCR, 48 h after the injection. CD74-positive cells were increased in diabetic 4-month retinas. These cells represented a subpopulation of CD11b-labeled activated microglia and were mainly located in the superficial vascular layer (13.7-fold increase compared to nondiabetic group). Methylglyoxal induced an 9.4-fold increase of CD74-positive cells in the superficial vascular layer and elevated gene expression of CD74 in the mouse retina 2.8-fold. In summary, we identified CD74 as a microglial activation marker in the diabetic retina. Exogenous methylglyoxal mimics the response in normoglycemic retina. This suggests that methylglyoxal is important in mediating microglial activation in the diabetic retina.
Similar content being viewed by others
References
Trento M, Passera P, Trevisan M, Schellino F, Sitia E et al (2013) Quality of life, impaired vision and social role in people with diabetes: a multicenter observational study. Acta Diabetol 50:873–877
Bandello F, Lattanzio R, Zucchiatti I, Del Turco C (2013) Pathophysiology and treatment of diabetic retinopathy. Acta Diabetol 50:1–20
Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366:1227–1239
Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107:1058–1070
Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625
Ibrahim AS, El-Shishtawy MM, Pena A Jr, Liou GI (2010) Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol Vis 16:2033–2042
Gaucher D, Chiappore JA, Paques M, Simonutti M, Boitard C et al (2007) Microglial changes occur without neural cell death in diabetic retinopathy. Vision Res 47:612–623
Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF et al (2005) Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54:1559–1565
McVicar CM, Hamilton R, Colhoun LM, Gardiner TA, Brines M et al (2011) Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes 60:2995–3005
Zeng HY, Green WR, Tso MO (2008) Microglial activation in human diabetic retinopathy. Arch Ophthalmol 126:227–232
Feng Y, Wang Y, Li L, Wu L, Hoffmann S et al (2011) Gene expression profiling of vasoregression in the retina–involvement of microglial cells. PLoS ONE 6:e16865
Feng Y, Wang Y, Stock O, Pfister F, Tanimoto N et al (2009) Vasoregression linked to neuronal damage in the rat with defect of polycystin-2. PLoS ONE 4:e7328
Marsh LM, Cakarova L, Kwapiszewska G, von Wulffen W, Herold S et al (2009) Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair. Am J Physiol Lung Cell Mol Physiol 296:L442–L452
Martin-Ventura JL, Madrigal-Matute J, Munoz-Garcia B, Blanco-Colio LM, Van Oostrom M et al (2009) Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells. Cardiovasc Res 83:586–594
Sanchez-Nino MD, Sanz AB, Ihalmo P, Lassila M, Holthofer H et al (2009) The MIF receptor CD74 in diabetic podocyte injury. J Am Soc Nephrol 20:353–362
Borghese F, Clanchy FI (2011) CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease. Expert Opin Ther Targets 15:237–251
McLellan AC, Phillips SA, Thornalley PJ (1992) The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene. Anal Biochem 206:17–23
Sartore G, Chilelli NC, Burlina S, Lapolla A (2013) Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes. Acta Diabetol 50:437–442
Abu El-Asrar AM, Mohammad G, Nawaz MI, Siddiquei MM, Kangave D et al (2013) Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy. Acta Diabetol 50:363–371
Gordin D, Kaaja R, Forsblom C, Hiilesmaa V, Teramo K et al (2013) Pre-eclampsia and pregnancy-induced hypertension are associated with severe diabetic retinopathy in type 1 diabetes later in life. Acta Diabetol 50:781–787
Calandra T, Roger T (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3:791–800
Block ML, Hong JS (2005) Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76:77–98
Lull ME, Block ML (2010) Microglial activation and chronic neurodegeneration. Neurotherapeutics 7:354–365
Stitt AW (2010) AGEs and diabetic retinopathy. Invest Ophthalmol Vis Sci 51:4867–4874
Acknowledgments
This study was supported by grants from the DFG (Deutsche Forschungsgemeinschaft), the DDG (Deutsche Diabetes Gesellschaft) and the EFSD (European Foundation for the Study of Diabetes). The authors thank P. Bugert and U. Kaiser for their excellent technical assistance.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standard
All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.
Human and animal rights
All applicable national and institutional guidelines for the care and use of animals were followed.
Informed consent
This article does not contain any studies with human participants performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
Managed by Antonio Secchi.
Rights and permissions
About this article
Cite this article
Wang, J., Lin, J., Schlotterer, A. et al. CD74 indicates microglial activation in experimental diabetic retinopathy and exogenous methylglyoxal mimics the response in normoglycemic retina. Acta Diabetol 51, 813–821 (2014). https://doi.org/10.1007/s00592-014-0616-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-014-0616-9